SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics appointed Victor Dzau, M.D., former President of…

UNITED THERAPEUTICS Corp · 8-K filed Jul 23, 2026 at 07:00 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jul 23, 2026 at 07:00 ET

United Therapeutics appointed Victor Dzau, M.D., former President of the National Academy of Medicine, to its Board of Directors on July 22, 2026. This is a routine board refreshment appointment of a highly credentialed academic and healthcare leader, with no material financial impact or change in corporate strategy disclosed. The filing contains no financial data, guidance, or operational updates.

  • Board size increased to 13 members with the appointment of Victor Dzau, M.D.
  • Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine.
  • Dr. Dzau received initial equity grants of 380 RSUs and 1,190 stock options, plus pro-rata grants of 350 RSUs and 1,110 stock options for the remainder of the 2026-2027 board service year.
  • No material transactions between Dr. Dzau and the company exceeding $120,000.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access